Tag: equity-research
UiPath Stock Analysis: Valuation, ARR Growth, Retention & Free Cash Flow
UiPath (PATH) earns a HOLD rating as its valuation already reflects a better monetization and margin story. ARR growth slowed to 11% and dollar-based net retention slipped to 107%, leaving execution and retention as the key watchpoints.
Abbott Laboratories Stock Analysis: Valuation, Margins, Debt & Growth
Abbott Laboratories (ABT) is rated Hold as its diversified healthcare platform supports stability, but valuation and execution concerns cap near-term upside. Q1 2026 revenue and EBIT weakened sequentially, while debt tied to acquisition financing could pressure flexibility.
Verizon Stock Analysis: Buy or Sell? VZ 5-Year Beta, Dividend & Valuation
Verizon Communications Inc. (VZ) earns a HOLD rating as its defensive cash flow and 7.5x EV/EBITDA valuation are offset by heavy leverage. Q1 2026 EBITDA rose 7.3% year over year, but $200.9B of debt keeps refinancing risk front and center.
Fastly, Inc. (FSLY) Edge Cloud Platform — Equity Research
Fastly, Inc. (FSLY) is rated a constructive hold on its programmable edge cloud platform and durable gross margins. Positive free cash flow and 81% gross margin support the thesis, though debt and customer concentration remain key risks.
Sky Harbour Stock Analysis: Valuation, Leverage, Cash Burn & Growth
Sky Harbour Group Corp. (SKYH) earns a SELL rating as its valuation already prices in a successful lease-up while profitability and cash generation remain weak. The company’s long-duration rental model supports growth, but $555.9M of debt and negative levered free cash flow make execution and refinancing the key risks.